Regulation of an endogenous locus using a panel of designed zinc finger proteins targeted to accessible chromatin regions. Activation of vascular endothelial growth factor A
- PMID: 11145970
- DOI: 10.1074/jbc.M011172200
Regulation of an endogenous locus using a panel of designed zinc finger proteins targeted to accessible chromatin regions. Activation of vascular endothelial growth factor A
Abstract
We have mapped conserved regions of enhanced DNase I accessibility within the endogenous chromosomal locus of vascular endothelial growth factor A (VEGF-A). Synthetic zinc finger protein (ZFP) transcription factors were designed to target DNA sequences contained within the DNase I-hypersensitive regions. These ZFPs, when fused to either VP16 or p65 transcriptional activation domains, were able to activate expression of the VEGF-A gene as assayed by mRNA accumulation and VEGF-A protein secretion through a range exceeding that induced by hypoxic stress. Importantly, multiple splice variants of VEGF-A mRNA with defined physiological functions were induced by a single engineered ZFP transcription factor. We present evidence for an enhanced activation of VEGF-A gene transcription by ZFP transcription factors fused to VP16 and p65 targeted to two distinct chromosomal sites >500 base pairs upstream or downstream of the transcription start site. Our strategy provides a novel approach for dissecting the requirements for gene regulation at a distance without altering the DNA sequence of the endogenous target locus.
Similar articles
-
Synthetic zinc finger transcription factor action at an endogenous chromosomal site. Activation of the human erythropoietin gene.J Biol Chem. 2000 Oct 27;275(43):33850-60. doi: 10.1074/jbc.M005341200. J Biol Chem. 2000. PMID: 10913152
-
Repression of vascular endothelial growth factor A in glioblastoma cells using engineered zinc finger transcription factors.Cancer Res. 2003 Dec 15;63(24):8968-76. Cancer Res. 2003. PMID: 14695215
-
Engineered zinc finger-activating vascular endothelial growth factor transcription factor plasmid DNA induces therapeutic angiogenesis in rabbits with hindlimb ischemia.Circulation. 2004 Oct 19;110(16):2467-75. doi: 10.1161/01.CIR.0000145139.53840.49. Epub 2004 Oct 11. Circulation. 2004. PMID: 15477407
-
Step out of the groove: epigenetic gene control systems and engineered transcription factors.Adv Genet. 2006;56:163-204. doi: 10.1016/S0065-2660(06)56005-5. Adv Genet. 2006. PMID: 16735158 Review.
-
Designer zinc-finger proteins and their applications.Gene. 2006 Jan 17;366(1):27-38. doi: 10.1016/j.gene.2005.09.011. Epub 2005 Nov 17. Gene. 2006. PMID: 16298089 Review.
Cited by
-
Epigenetic Regulation of β-Globin Genes and the Potential to Treat Hemoglobinopathies through Epigenome Editing.Genes (Basel). 2023 Feb 25;14(3):577. doi: 10.3390/genes14030577. Genes (Basel). 2023. PMID: 36980849 Free PMC article. Review.
-
Genome-wide functional perturbation of human microsatellite repeats using engineered zinc finger transcription factors.Cell Genom. 2022 Apr 13;2(4):100119. doi: 10.1016/j.xgen.2022.100119. Cell Genom. 2022. PMID: 35967079 Free PMC article.
-
Chromatin Alterations in Neurological Disorders and Strategies of (Epi)Genome Rescue.Pharmaceuticals (Basel). 2021 Aug 4;14(8):765. doi: 10.3390/ph14080765. Pharmaceuticals (Basel). 2021. PMID: 34451862 Free PMC article. Review.
-
Genome-wide investigation of the dynamic changes of epigenome modifications after global DNA methylation editing.Nucleic Acids Res. 2021 Jan 11;49(1):158-176. doi: 10.1093/nar/gkaa1169. Nucleic Acids Res. 2021. PMID: 33300025 Free PMC article.
-
Epigenome engineering: new technologies for precision medicine.Nucleic Acids Res. 2020 Dec 16;48(22):12453-12482. doi: 10.1093/nar/gkaa1000. Nucleic Acids Res. 2020. PMID: 33196851 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources